Increased levels of IL-23 correlate with increased levels of MMPs as detected in mouse models such as TLR4 knock-out mice [69] and in human peripheral blood of patients with relapsing-remitting multiple sclerosis [70]. This evidence concerns the gene IL37 and relapsing-remitting multiple sclerosis.